Obesity triggers enhanced MDSC accumulation in murine renal tumors via elevated local production of CCL2

PloS One
Malika HaleLyse A Norian

Abstract

Obesity is one of the leading risk factors for developing renal cell carcinoma, an immunogenic tumor that is treated clinically with immunostimulatory therapies. Currently, however, the mechanisms linking obesity with renal cancer incidence are unclear. Using a model of diet-induced obesity, we found that obese BALB/c mice with orthotopic renal tumors had increased total frequencies of myeloid-derived suppressor cells (MDSC) in renal tumors and spleens by d14 post-tumor challenge, relative to lean counterparts. Renal tumors from obese mice had elevated concentrations of the known myeloid cell chemoattractant CCL2, which was produced locally by increased percentages of dendritic cells, macrophages, B cells, and CD45- cells in tumors. MDSC expression of the CCL2 receptor, CCR2, was unaltered by obesity but greater percentages of CCR2+ MDSCs were present in renal tumors from obese mice. Of note, the intracellular arginase levels and per-cell suppressive capacities of tumor-infiltrating and splenic MDSCs were unchanged in obese mice relative to lean controls. Thus, our findings suggest that obesity promotes renal tumor progression via development of a robust immunosuppressive environment that is characterized by heightened local an...Continue Reading

References

Dec 21, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stephanie K BuntSuzanne Ostrand-Rosenberg
Jan 27, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Augusto C OchoaPaulo C Rodriguez
Jan 26, 2008·Obesity Surgery·Victoria CatalánGema Frühbeck
Mar 8, 2008·Current Opinion in Genetics & Development·Paola AllavenaAlberto Mantovani
May 22, 2008·The Journal of Clinical Endocrinology and Metabolism·Joakim HuberThomas M Stulnig
Feb 7, 2009·Nature Reviews. Immunology·Dmitry I Gabrilovich, Srinivas Nagaraj
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hanne Krogh JensenHans von der Maase
Jan 15, 2010·JAMA : the Journal of the American Medical Association·Katherine M FlegalLester R Curtin
Mar 23, 2010·Cell·Sergei I GrivennikovMichael Karin
May 8, 2010·Nature Reviews. Urology·Wong-Ho ChowSusan S Devesa
Aug 10, 2010·Urologia Internationalis·Yukio NayaTatsuo Igarashi
Sep 29, 2011·Journal of Leukocyte Biology·Je-In YounDmitry I Gabrilovich
Jun 30, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Britnie R JamesLyse A Norian
Nov 6, 2012·Annual Review of Medicine·Candace A Gilbert, Joyce M Slingerland
Nov 16, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Eva SchleckerAdelheid Cerwenka
Dec 21, 2012·The Journal of Urology·Yao ZhuDing-Wei Ye
Aug 21, 2013·Cancer Research·Lisa M ArendtCharlotte Kuperwasser
Mar 13, 2014·International Journal of Cancer. Journal International Du Cancer·Furan Wang, Yinghua Xu
May 20, 2014·Immunologic Research·Vincent Chehval, Lyse A Norian
May 23, 2014·International Journal of Cancer. Journal International Du Cancer·Jae In JungJung Han Yoon Park
Aug 22, 2014·Cancer Immunology, Immunotherapy : CII·Britnie R JamesThomas S Griffith
Jun 17, 2015·Mediators of Inflammation·Hiroshi Katoh, Masahiko Watanabe

❮ Previous
Next ❯

Citations

Sep 4, 2015·Molecular Nutrition & Food Research·Vasso ApostolopoulosBarbora de Courten
Aug 17, 2016·Journal of Immunology Research·Irina Lyadova VladimirovnaTatiana Nenasheva
May 16, 2018·Journal of Leukocyte Biology·Robert J CanterWilliam J Murphy
Feb 2, 2019·Nutrition Research Reviews·Sabrina CampisanoAndrea N Chisari
Apr 25, 2018·Nature Medicine·Mikhail BinnewiesMatthew F Krummel
Jul 10, 2018·Carcinogenesis·Chiara PortaAntonio Sica
Dec 18, 2018·Frontiers in Immunology·Snehil BudhwarKiran Singh
Aug 23, 2020·Cancers·Christopher M WrightNicole L Simone
May 27, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David Kung-Chun ChiuCarmen Chak-Lui Wong
Aug 24, 2019·Frontiers in Immunology·Kathleen FriedrichManuela Rossol
Aug 23, 2020·International Journal of Molecular Sciences·Augusto BleveFrancesca Maria Consonni
Oct 21, 2020·Cellular & Molecular Immunology·Laura StraussAntonio Sica
Nov 11, 2020·ELife·Jefte M DrijversMarcia C Haigis
Jan 12, 2021·Journal for Immunotherapy of Cancer·Shannon K BoiLyse A Norian
Feb 16, 2021·Cellular Immunology·Elena JachettiMario P Colombo
Feb 17, 2021·Cellular Immunology·Maria Dulfary Sanchez-PinoAugusto C Ochoa
Feb 20, 2021·Cancer Gene Therapy·Karan KohliTeresa S Kim
Mar 16, 2018·Current Opinion in Immunology·Suzanne Ostrand-Rosenberg
Mar 4, 2021·Disease Models & Mechanisms·Cara E WogslandNils Halberg
May 15, 2021·Seminars in Cancer Biology·Nikolaos SpyrouMaria Dalamaga
Jun 26, 2021·Pharmacology & Therapeutics·Lysanne DesharnaisDaniela F Quail
Aug 24, 2021·Disease Models & Mechanisms·Cara E WogslandNils Halberg

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
ELISA
Flow cytometry gating

Software Mentioned

FlowJo

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.